These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17455097)

  • 1. Macrophagic myofasciitis in childhood: the role of scanning electron microscopy/energy-dispersive spectroscopy for diagnosis.
    Kalil RK; Monteiro A; Lima MI; Silveira EB; Foltran FS; Martins CE; Rizzo IM
    Ultrastruct Pathol; 2007; 31(1):45-50. PubMed ID: 17455097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophagic myofasciitis in children is a localized reaction to vaccination.
    Lach B; Cupler EJ
    J Child Neurol; 2008 Jun; 23(6):614-9. PubMed ID: 18281624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophagic myofasciitis in childhood: a controversial entity.
    Rivas E; Gómez-Arnáiz M; Ricoy JR; Mateos F; Simón R; García-Peñas JJ; Garcia-Silva MT; Martín E; Vázquez M; Ferreiro A; Cabello A
    Pediatr Neurol; 2005 Nov; 33(5):350-6. PubMed ID: 16243223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood macrophagic myofasciitis-consanguinity and clinicopathological features.
    Nevo Y; Kutai M; Jossiphov J; Livne A; Neeman Z; Arad T; Popovitz-Biro R; Atsmon J; Shapira Y; Soffer D
    Neuromuscul Disord; 2004 Apr; 14(4):246-52. PubMed ID: 15019702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric macrophagic myofasciitis associated with motor delay.
    Gruis KL; Teener JW; Blaivas M
    Clin Neuropathol; 2006; 25(4):172-9. PubMed ID: 16866298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccine adjuvants and macrophagic myofasciitis].
    Siegrist CA
    Bull Acad Natl Med; 2003; 187(8):1511-8; discussion 1519-21. PubMed ID: 15146582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity.
    Chkheidze R; Burns DK; White CL; Castro D; Fuller J; Cai C
    J Neuropathol Exp Neurol; 2017 Apr; 76(4):323-331. PubMed ID: 28340105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophagic myofasciitis associated with vaccine-derived aluminium.
    Shingde M; Hughes J; Boadle R; Wills EJ; Pamphlett R
    Med J Aust; 2005 Aug; 183(3):145-6. PubMed ID: 16053418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood oxidative stress status in patients with macrophagic myofasciitis.
    Bonnefont-Rousselot D; Chantalat-Auger C; Teixeira A; Jaudon MC; Pelletier S; Cherin P
    Biomed Pharmacother; 2004 Nov; 58(9):516-9. PubMed ID: 15511609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI and 31PMR spectroscopy investigations of muscle function disclose no abnormality in macrophagic myofasciitis.
    Guis S; Mattei JP; Pellissier JF; Nicoli F; Figarella-Branger D; Le Fur Y; Kaplanski G; Pelletier J; Harle JR; Cozzone PJ; Bendahan D
    J Rheumatol; 2004 Nov; 31(11):2313-4. PubMed ID: 15517654
    [No Abstract]   [Full Text] [Related]  

  • 11. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.
    Gherardi RK; Coquet M; Cherin P; Belec L; Moretto P; Dreyfus PA; Pellissier JF; Chariot P; Authier FJ
    Brain; 2001 Sep; 124(Pt 9):1821-31. PubMed ID: 11522584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aluminum phagocytosis in quadriceps muscle following vaccination in children: relationship to macrophagic myofasciitis.
    Lacson AG; D'Cruz CA; Gilbert-Barness E; Sharer L; Jacinto S; Cuenca R
    Pediatr Dev Pathol; 2002; 5(2):151-8. PubMed ID: 11910509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].
    Gherardi RK
    Rev Neurol (Paris); 2003 Feb; 159(2):162-4. PubMed ID: 12660567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophagic myofasciitis unrelated to vaccination.
    Park JH; Na KS; Park YW; Paik SS; Yoo DH
    Scand J Rheumatol; 2005; 34(1):65-7. PubMed ID: 15903029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants.
    Kim H; Lim KY; Kang J; Park JW; Park SH
    Sci Rep; 2020 Jul; 10(1):11834. PubMed ID: 32678281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophagic myofasciitis plus (distinct types of muscular dystrophy).
    Müller HD; Landeghem FK; Schmidt PF; Sommer C; Goebel HH
    Neuropediatrics; 2009 Aug; 40(4):174-8. PubMed ID: 20135575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health. Aluminum is put on trial as a vaccine booster.
    Malakoff D
    Science; 2000 May; 288(5470):1323-4. PubMed ID: 10847840
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophagic myofasciitis: a summary of Dr. Gherardi's presentations.
    Brenner A
    Vaccine; 2002 May; 20 Suppl 3():S5-6. PubMed ID: 12184366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Macrophagic myofasciitis: inflammatory, vaccination-associated muscular disease].
    Fischer D; Reimann J; Schröder R
    Dtsch Med Wochenschr; 2003 Oct; 128(44):2305-8. PubMed ID: 14593574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system.
    Gherardi RK; Crépeaux G; Authier FJ
    Autoimmun Rev; 2019 Jul; 18(7):691-705. PubMed ID: 31059838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.